查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433435

全球外骨骼市場 2023-2030

Global Exoskeleton Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2024-2031年），全球外骨骼市場將以 12.4%的CAGR成長。推動外骨骼市場的重要因素包括脊髓損傷發生率的上升，外骨骼研發投資的增加以及政府政策的凝聚力。根據國家脊髓損傷統計中心（NSCISC）2023年的資料，美國創傷性脊髓損傷（tSCI）的年發病率最新估計約為每百萬人 54 例，相當於每年約新增 18,000 例 tSCI 病例年。此外，私營和公共部門對外骨骼技術開發的投資不斷增加，進一步促進了市場成長。2023年 12月，劍橋外骨骼開發商 Verve Motion 籌集了2000 萬美元的 B 輪資金，以擴大其 SafeLift 軟外骨骼的規模。 SafeLift 像背包一樣穿著，利用即時運動感應和機器人輔助，可減輕典型工作日工人背部 40%的壓力。

細分市場前景

全球外骨骼市場依類型、移動性和最終用戶進行細分。根據類型，市場分為動力外骨骼和被動外骨骼。根據移動性，市場分為移動和固定/固定。此外，根據最終用戶，市場分為醫療、工業和軍事。在這些類型中，動力外骨骼細分市場預計將佔據很大的市場佔有率，這主要歸因於減少工業中的身體壓力、提高生產力和復健支持。

預計行動細分市場將在全球外骨骼市場中佔據相當大的佔有率

在行動領域中，行動細分市場預計將在全球外骨骼市場中佔據相當大的佔有率。此細分市場的成長歸因於為行動不便的個人提供站立能力、促進獨立性和提高生活品質，以及移動外骨骼技術的不斷進步和監管部門的批准。此外，主要參與者也在不同地區拓展業務，以滿足移動外骨骼的需求。例如，2023年 10月，Wandercraft 與凱斯勒基金會合作，在美國推出了 Atalante X 移動外骨骼的商業運作。這款免持設備經 FDA 批准用於中風康復，利用自平衡技術和遊戲化功能進行物理治療。在2022年 12月獲得 FDA 批准 Atalante 用於中風復原後，Wandercraft 策略性地擴大了在美國的足跡。該公司在紐約建立了新的營運基地，以增強其市場影響力並支援 Atalante 在該地區的部署。該設備於2019年獲准在歐盟使用，此後已用於治療 650 多名患者，進行了 5,000 多次治療。

區域展望

全球外骨骼市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國、亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於外骨骼在軍事和國防應用中的使用越來越多，包括士兵增強和負重輔助，預計歐洲將在全球市場中佔據顯著佔有率，這有助於歐洲市場的擴張。

北美地區預計全球外骨骼市場複合CAGR顯著成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。區域市場的成長歸因於醫療保健中擴大採用外骨骼進行復健和政府的支持性舉措，以及工業環境中擴大採用外骨骼以提高工人的安全和生產力。根據美國勞工統計局的資料，2022年美國有5,486起致命工傷，比2021年的5,190起增加了5.7%。致命工傷率為每10萬名全職當量工人中有3.7人死亡，到2021年，每10 萬名全職員工中的3.6 人將增加。此外，外骨骼製造商、技術公司和研究機構之間不斷加強的合作也促進了該地區的創新和市場成長。2024年 1月，理查德和洛恩希爾生物醫學工程系的 Ming Wu 教授獲得了伊利諾伊大學芝加哥分校和 OSF Healthcare 的合作資助，用於創建用於護理的外骨骼。該計畫目的是為護理人員製造外骨骼，以避免與重複性任務和長時間輪班相關的腰痛和受傷風險。

市場參與者展望

服務外骨骼市場的主要公司包括 Bionik Laboratories、Bioness Inc.、Cyber​​dyne Inc.、Ekso Bionics Holdings, Inc.、ReWalk Robotics Ltd. 等。市場參與者透過各種策略（包括併購、夥伴關係、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022年 6月，Ekso Bionics 為其專為多發性硬化症（MS）患者設計的 EksoNR 機器人外骨骼獲得了 FDA 510（k）許可。這標誌著 FDA 首次批准外骨骼復健用於多發性硬化症患者，擴大了該設備的應用範圍。

報告涵蓋：

  • 2023年市場價值資料分析及2031年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 在全球外骨骼市場中營運的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第1章 報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 依地區

第2章 市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第3章 競爭格局

  • 主要公司分析
  • Bionik Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Bioness Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Cyberdyne Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Ekso Bionics Holdings, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • ReWalk Robotics Ltd.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第4章 市場細分

  • 依類型分類的全球外骨骼市場
    • 動力外骨骼
    • 被動外骨骼
  • 按移動性分類的全球外骨骼市場
    • 移動
    • 固定
  • 依最終用戶分類的全球外骨骼市場
    • 醫療
    • 工業
    • 軍隊

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第6章 公司簡介

  • 3DR, Inc.
  • American Honda Motor Co., Inc.
  • ATOUN Inc.
  • B-Temia Inc.
  • Hocoma AG
  • Lockheed Martin Corp.
  • Myomo Inc.
  • noonee germany GmbH
  • Parker Hannifin Corp.
  • Rex Bionics Ltd
  • Roam Robotics
  • Sarcos Technology and Robotics Corp.
  • SuitX
  • US Bionics, Inc.
Product Code: OMR2028086

Global Exoskeleton Market Size, Share & Trends Analysis Report by Type (Powered Exoskeletons and Passive Exoskeletons), by Mobility (Mobile and Fixed/Stationary), and by End-User (Medical, Industrial, and Military), Forecast Period (2024-2031)

The global exoskeleton market is anticipated to grow at a CAGR of 12.4% during the forecast period (2024-2031). Significant factors contributing to the exoskeleton market include the growing incidence rate of spinal cord injuries, increasing investment in R&D of the exoskeleton, and cohesive government policies. As per the National Spinal Cord Injury Statistical Center (NSCISC) 2023, the most recent estimate of the annual incidence of traumatic spinal cord injury (tSCI) is approximately 54 cases per one million people in the US, which equals about 18,000 new tSCI cases each year. Additionally, growing investments from private and public sectors in the development of exoskeleton technologies further contribute to market growth. In December 2023, Verve Motion, a Cambridge-based exoskeleton developer, raised $20 million in Series B funding to scale its SafeLift soft exoskeleton. SafeLift, worn like a backpack, utilizes real-time motion sensing and robotic assistance to alleviate 40% of the strain on a worker's back during a typical workday.

Segmental Outlook

The global exoskeleton market is segmented by type, mobility, and end-user. Based on the type, the market is sub-segmented into powered exoskeletons and passive exoskeletons. Based on mobility, the market is sub-segmented into mobile and fixed/stationary. Further, based on the end-user, the market is sub-segmented into medical, industrial, and military. Among the types, the powered exoskeletons sub-segment is projected to hold a significant share of the market, primarily attributed to reducing physical strain in industries, improving productivity, and rehabilitation support.

The Mobile Sub-Segment is Anticipated to Hold a Considerable Share of the Global Exoskeleton Market

Among the mobility, the mobile sub-segment is expected to hold a considerable share of the global exoskeleton market. The segmental growth is attributed to providing individuals with mobility impairments the ability to stand, promoting independence and improved quality of life, and continuous advancements in mobile exoskeleton technology, and regulatory approvals. In addition, the key players are also expanding their business in different regions to cater to the demand for mobile exoskeletons. For instance, in October 2023, Wandercraft launched commercial operations in the US for its Atalante X mobility exoskeleton, partnering with the Kessler Foundation. FDA-approved for stroke rehabilitation, the hands-free device utilizes self-balancing technology and gamified features for engaging in physiotherapy. After securing FDA approval in December 2022 for Atalante's utilization in stroke rehabilitation, Wandercraft strategically expanded its footprint in the US. The company established a new operational base in New York to enhance its market presence and support the deployment of Atalante in the region. The device was approved for use in the EU in 2019 and has since been used to treat over 650 patients across over 5,000 sessions.

Regional Outlook

The global exoskeleton market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the growing use of exoskeletons in military and defense applications, including soldier augmentation and load-bearing assistance, which contributes to market expansion in Europe.

The North America Region is Expected to Grow at a Significant CAGR in the Global Exoskeleton Market

Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. The regional market growth is attributed to the growing adoption of exoskeletons in healthcare for rehabilitation and supportive government initiatives and the increasing adoption of exoskeletons in industrial settings to enhance worker safety and productivity. According to the US Bureau of Labor Statistics, there were 5,486 fatal work injuries recorded in the US in 2022, marking a 5.7% increase from the 5,190 recorded in 2021. The fatal work injury rate was 3.7 fatalities per 100,000 full-time equivalent workers, up from 3.6 per 100,000 full-time equivalents in 2021. In addition, increasing collaborations between exoskeleton manufacturers, technology firms, and research institutions bolster innovation and market growth in the region. In January 2024, Prof. Ming Wu at the Richard and Loan Hill Department of Biomedical Engineering received a collaborative grant from the University of Illinois Chicago and OSF Healthcare to create an exoskeleton for nursing. The project aimed to create an exoskeleton for nursing staff to avoid lower back pain and injury risks associated with repetitive tasks and long shifts.

Market Players Outlook

The major companies serving the exoskeleton market include Bionik Laboratories, Bioness Inc., Cyberdyne Inc., Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2022, Ekso Bionics received FDA 510(k) clearance for its EksoNR robotic exoskeleton designed for Multiple Sclerosis (MS) patients. This marked the first FDA clearance for exoskeleton rehabilitation use in MS patients, broadening the device's application.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global exoskeleton market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Bionik Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bioness Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Cyberdyne Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Ekso Bionics Holdings, Inc.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. ReWalk Robotics Ltd.
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
    • 3.6.4. Recent Developments
  • 3.7. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Exoskeleton Market by Type
    • 4.1.1. Powered Exoskeletons
    • 4.1.2. Passive Exoskeletons
  • 4.2. Global Exoskeleton Market by Mobility
    • 4.2.1. Mobile
    • 4.2.2. Fixed/Stationary
  • 4.3. Global Exoskeleton Market by End-User
    • 4.3.1. Medical
    • 4.3.2. Industrial
    • 4.3.3. Military

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 3DR, Inc.
  • 6.2. American Honda Motor Co., Inc.
  • 6.3. ATOUN Inc.
  • 6.4. B-Temia Inc.
  • 6.5. Hocoma AG
  • 6.6. Lockheed Martin Corp.
  • 6.7. Myomo Inc.
  • 6.8. noonee germany GmbH
  • 6.9. Parker Hannifin Corp.
  • 6.10. Rex Bionics Ltd
  • 6.11. Roam Robotics
  • 6.12. Sarcos Technology and Robotics Corp.
  • 6.13. SuitX
  • 6.14. US Bionics, Inc.

LIST OF TABLES

  • 1. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 2. GLOBAL POWERED EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3. GLOBAL PASSIVE EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 5. GLOBAL MOBILE EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 6. GLOBAL FIXED/STATIONARY EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 7. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 8. GLOBAL EXOSKELETON FOR MEDICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9. GLOBAL EXOSKELETON FOR INDUSTRIAL MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 10. GLOBAL EXOSKELETON FOR MILITARY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 11. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 12. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 13. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 14. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 15. NORTH AMERICAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 16. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 17. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 18. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 19. EUROPEAN EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 20. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 21. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 22. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 23. ASIA-PACIFIC EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 24. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 25. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 26. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY MOBILITY, 2023-2031 ($ MILLION)
  • 27. REST OF THE WORLD EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL EXOSKELETON MARKET SHARE BY TYPE, 2023 VS 2031 (%)
  • 2. GLOBAL POWERED EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 3. GLOBAL PASSIVE EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 4. GLOBAL EXOSKELETON MARKET SHARE BY MOBILITY, 2023 VS 2031 (%)
  • 5. GLOBAL MOBILE EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 6. GLOBAL FIXED/STATIONARY EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 7. GLOBAL EXOSKELETON MARKET RESEARCH AND ANALYSIS BY END-USER, 2023 VS 2031 (%)
  • 8. GLOBAL EXOSKELETON FOR MEDICAL MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 9. GLOBAL EXOSKELETON FOR INDUSTRIAL MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 10. GLOBAL EXOSKELETON FOR MILITARY MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 11. GLOBAL EXOSKELETON MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 12. US EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 13. CANADA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 14. UK EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 15. FRANCE EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 16. GERMANY EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 17. ITALY EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 18. SPAIN EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 19. REST OF EUROPE EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 20. INDIA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 21. CHINA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 22. JAPAN EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 23. SOUTH KOREA EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)
  • 25. REST OF THE WORLD EXOSKELETON MARKET SIZE, 2023-2031 ($ MILLION)